In AML patients FLT3/ITD and/or genomic breakpoints of different fusion genes (PML/RARalpha, CBFbeta/MYH11, AML1/ETO, MLL/AF6, MLL/AF9, and MLL/AF10) were used as clonal markers. The gene discussed is PML; the disease is acute myeloid leukemia.